{"id":"https://openalex.org/W4411159595","doi":"https://doi.org/10.2147/dddt.s509176","title":"Development and Validation of a UPLC-MS/MS Detection Method of Baricitinib for Therapeutic Drug Monitoring in COVID-19 Patients","display_name":"Development and Validation of a UPLC-MS/MS Detection Method of Baricitinib for Therapeutic Drug Monitoring in COVID-19 Patients","alternate_titles":[],"publication_year":2025,"publication_date":"2025-06-01","ids":{"openalex":"https://openalex.org/W4411159595","doi":"https://doi.org/10.2147/dddt.s509176","pmid":"https://pubmed.ncbi.nlm.nih.gov/40521007","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/12164873"},"language":"en","primary_location":{"id":"doi:10.2147/dddt.s509176","doi":"https://doi.org/10.2147/dddt.s509176","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dddt.s509176","pdf_url":"https://www.dovepress.com/article/download/103707","source":{"id":"https://openalex.org/S2496126384","display_name":"Drug Design Development and Therapy","issn_l":"1177-8881","issn":["1177-8881"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Design, Development and Therapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4411159595"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.dovepress.com/article/download/103707","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035457679","display_name":"Ruanjuan Zhan","orcid":"https://orcid.org/0000-0002-5046-9806","observed_orcids":["https://orcid.org/0000-0002-5046-9806"]},"institutions":[{"id":"https://openalex.org/I2801769982","display_name":"First Affiliated Hospital of Wenzhou Medical University","ror":"https://ror.org/03cyvdv85","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2801769982"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ruanjuan Zhan","raw_affiliation_strings":["Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China"],"raw_orcid":"https://orcid.org/0000-0002-5046-9806","affiliations":[{"raw_affiliation_string":"Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China","institution_ids":["https://openalex.org/I2801769982"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101311753","display_name":"Yuxin Shen","orcid":"https://orcid.org/0009-0004-1742-0797","observed_orcids":["https://orcid.org/0009-0004-1742-0797"]},"institutions":[{"id":"https://openalex.org/I2801769982","display_name":"First Affiliated Hospital of Wenzhou Medical University","ror":"https://ror.org/03cyvdv85","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2801769982"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yuxin Shen","raw_affiliation_strings":["Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China","institution_ids":["https://openalex.org/I2801769982"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Haoxin Fu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801769982","display_name":"First Affiliated Hospital of Wenzhou Medical University","ror":"https://ror.org/03cyvdv85","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2801769982"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Haoxin Fu","raw_affiliation_strings":["Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China","institution_ids":["https://openalex.org/I2801769982"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109791124","display_name":"Hualu Wu","orcid":"https://orcid.org/0009-0005-5976-5352","observed_orcids":["https://orcid.org/0009-0005-5976-5352"]},"institutions":[{"id":"https://openalex.org/I2801769982","display_name":"First Affiliated Hospital of Wenzhou Medical University","ror":"https://ror.org/03cyvdv85","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2801769982"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Hualu Wu","raw_affiliation_strings":["Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China","institution_ids":["https://openalex.org/I2801769982"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064388007","display_name":"Xiaohai Chen","orcid":"https://orcid.org/0009-0009-5017-5515","observed_orcids":["https://orcid.org/0009-0009-5017-5515"]},"institutions":[{"id":"https://openalex.org/I2801769982","display_name":"First Affiliated Hospital of Wenzhou Medical University","ror":"https://ror.org/03cyvdv85","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2801769982"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xiaohai Chen","raw_affiliation_strings":["Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China"],"raw_orcid":"https://orcid.org/0009-0009-5017-5515","affiliations":[{"raw_affiliation_string":"Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China","institution_ids":["https://openalex.org/I2801769982"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076708754","display_name":"Yige Yu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801769982","display_name":"First Affiliated Hospital of Wenzhou Medical University","ror":"https://ror.org/03cyvdv85","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2801769982"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Yige Yu","raw_affiliation_strings":["Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China","institution_ids":["https://openalex.org/I2801769982"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002627636","display_name":"Ren-ai Xu","orcid":"https://orcid.org/0000-0002-8238-6503","observed_orcids":["https://orcid.org/0000-0002-8238-6503","https://orcid.org/0000-0003-0572-0763"]},"institutions":[{"id":"https://openalex.org/I2801769982","display_name":"First Affiliated Hospital of Wenzhou Medical University","ror":"https://ror.org/03cyvdv85","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2801769982"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Ren-Ai Xu","raw_affiliation_strings":["Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China","institution_ids":["https://openalex.org/I2801769982"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5002627636","https://openalex.org/A5076708754"],"corresponding_institution_ids":["https://openalex.org/I2801769982"],"apc_list":{"value":2836,"currency":"USD","value_usd":2836},"apc_paid":{"value":2836,"currency":"USD","value_usd":2836},"fwci":0.6007,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.58421228,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":96},"biblio":{"volume":"Volume 19","issue":null,"first_page":"4957","last_page":"4966"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.6898999810218811,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.6898999810218811,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.2957000136375427,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/baricitinib","display_name":"baricitinib","score":1.0},{"id":"https://openalex.org/keywords/therapeutic-drug-monitoring","display_name":"therapeutic drug monitoring","score":0.9800000190734863},{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.9900000095367432},{"id":"https://openalex.org/keywords/plasma-drug-concentration","display_name":"plasma drug concentration","score":0.6769999861717224},{"id":"https://openalex.org/keywords/uplc-ms-ms-method-development","display_name":"UPLC-MS/MS method development","score":0.7929999828338623},{"id":"https://openalex.org/keywords/jak-inhibitors","display_name":"JAK inhibitors","score":0.8849999904632568},{"id":"https://openalex.org/keywords/method-validation","display_name":"method validation","score":0.5770000219345093},{"id":"https://openalex.org/keywords/matrix-effects","display_name":"matrix effects","score":0.42500001192092896}],"concepts":[{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.8004661798477173},{"id":"https://openalex.org/C2780272996","wikidata":"https://www.wikidata.org/wiki/Q1261151","display_name":"Therapeutic drug monitoring","level":3,"score":0.7161613702774048},{"id":"https://openalex.org/C3007834351","wikidata":"https://www.wikidata.org/wiki/Q82069695","display_name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","level":5,"score":0.6059474945068359},{"id":"https://openalex.org/C3006700255","wikidata":"https://www.wikidata.org/wiki/Q81068910","display_name":"2019-20 coronavirus outbreak","level":3,"score":0.5973023772239685},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5345586538314819},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4159155488014221},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.36951524019241333},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3508882522583008},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.23790618777275085},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.16823109984397888},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1652548909187317},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0},{"id":"https://openalex.org/C116675565","wikidata":"https://www.wikidata.org/wiki/Q3241045","display_name":"Outbreak","level":2,"score":0.0},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000086382","descriptor_name":"COVID-19","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000086402","descriptor_name":"SARS-CoV-2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000093485","descriptor_name":"COVID-19 Drug Treatment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000097922","descriptor_name":"Liquid Chromatography-Mass Spectrometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001384","descriptor_name":"Azetidines","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D001384","descriptor_name":"Azetidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002851","descriptor_name":"Chromatography, High Pressure Liquid","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011687","descriptor_name":"Purines","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015203","descriptor_name":"Reproducibility of Results","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D053719","descriptor_name":"Tandem Mass Spectrometry","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":6,"locations":[{"id":"doi:10.2147/dddt.s509176","doi":"https://doi.org/10.2147/dddt.s509176","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dddt.s509176","pdf_url":"https://www.dovepress.com/article/download/103707","source":{"id":"https://openalex.org/S2496126384","display_name":"Drug Design Development and Therapy","issn_l":"1177-8881","issn":["1177-8881"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Design, Development and Therapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:10976009","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/12164873","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:40521007","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40521007","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug design, development and therapy","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:12164873","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12164873/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Des Devel Ther","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:cd9911c743384ff39ee9d35d8b2ec63e","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/cd9911c743384ff39ee9d35d8b2ec63e","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Drug Design, Development and Therapy, Vol Volume 19, Iss Issue 1, Pp 4957-4966 (2025)","raw_type":"article"},{"id":"pmh:oai:dovepress.com/103707","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/development-and-validation-of-a-uplc-msms-detection-method-of-bariciti-peer-reviewed-fulltext-article-DDDT","pdf_url":null,"source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.2147/dddt.s509176","doi":"https://doi.org/10.2147/dddt.s509176","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dddt.s509176","pdf_url":"https://www.dovepress.com/article/download/103707","source":{"id":"https://openalex.org/S2496126384","display_name":"Drug Design Development and Therapy","issn_l":"1177-8881","issn":["1177-8881"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Design, Development and Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4411159595.pdf","grobid_xml":"https://content.openalex.org/works/W4411159595.grobid-xml"},"referenced_works_count":22,"referenced_works":["https://openalex.org/W1975165863","https://openalex.org/W2474139188","https://openalex.org/W2769096731","https://openalex.org/W2979907690","https://openalex.org/W3008526620","https://openalex.org/W3013347583","https://openalex.org/W3014471436","https://openalex.org/W3098853825","https://openalex.org/W3113196149","https://openalex.org/W3195786665","https://openalex.org/W3197608731","https://openalex.org/W4229042774","https://openalex.org/W4281393347","https://openalex.org/W4283264561","https://openalex.org/W4283266668","https://openalex.org/W4288459457","https://openalex.org/W4305014652","https://openalex.org/W4381486259","https://openalex.org/W4383875351","https://openalex.org/W4387077122","https://openalex.org/W4388011834","https://openalex.org/W4390791027"],"related_works":["https://openalex.org/W7203651857","https://openalex.org/W7165533931","https://openalex.org/W4381486259","https://openalex.org/W4387077122","https://openalex.org/W7124834345","https://openalex.org/W3014471436","https://openalex.org/W7160101596","https://openalex.org/W4386860626","https://openalex.org/W3195028339","https://openalex.org/W6930611670"],"abstract_inverted_index":{"Background:":[0],"Baricitinib":[1],"is":[2,22,46,59,201],"widely":[3],"used":[4],"as":[5],"a":[6,72],"selective":[7],"Janus":[8],"kinase":[9],"(JAK)":[10],"inhibitor":[11],"for":[12,203],"the":[13,37,48,51,77,99,126,141,154,170,175,204],"treatment":[14,58],"of":[15,36,41,50,53,66,79,98,107,112,122,140,168,174,194,209],"immune-mediated":[16],"inflammatory":[17],"diseases":[18],"in":[19,26,43,55,81,157,197],"clinic.":[20],"It":[21],"now":[23],"successfully":[24],"applied":[25],"reducing":[27],"inflammation":[28],"and":[29,61,109,130,133,138,180,191],"suppressing":[30],"COVID-19-associated":[31],"immune":[32],"dysregulation.":[33],"As":[34],"knowledge":[35],"appropriate":[38],"plasma":[39,56,84,108,155,172],"level":[40,52],"baricitinib":[42,54,80,195],"COVID-19":[44,82,159],"patients":[45,176],"deficient,":[47],"measurement":[49],"during":[57],"necessary":[60],"important.":[62],"Purpose:":[63],"The":[64,95,128,148],"aim":[65],"this":[67],"study":[68],"was":[69,102,150],"to":[70,75,103,124,152],"establish":[71],"bioanalytical":[73],"method":[74,149,188],"detect":[76],"concentration":[78],"patients'":[83],"by":[85],"ultra":[86],"performance":[87],"liquid":[88],"chromatography":[89],"tandem":[90],"mass":[91],"spectrometry":[92],"(UPLC-MS/MS).":[93],"Methods:":[94],"preparation":[96],"process":[97],"injected":[100],"sample":[101],"spike":[104],"100":[105],"\u03bcL":[106,111],"10":[110],"internal":[113],"standard":[114],"(IS,":[115],"upadacitinib)":[116],"working":[117],"solution,":[118],"then":[119],"add":[120],"1:3":[121],"acetonitrile":[123],"obtain":[125],"supernatant.":[127],"intra-day":[129],"inter-day":[131],"precision":[132],"accuracy,":[134],"matrix":[135],"effect,":[136],"recovery,":[137],"stability":[139],"established":[142,151],"methodology":[143],"were":[144,177],"all":[145],"required.":[146],"Results:":[147],"determine":[153],"levels":[156],"22":[158],"patients.":[160],"After":[161],"taking":[162],"2":[163],"mg/day":[164,167],"or":[165],"4":[166],"baricitinib,":[169],"mean":[171],"concentrations":[173,196],"15.36":[178],"ng/mL":[179],"12.64":[181],"ng/mL,":[182],"respectively.":[183],"Conclusion:":[184],"This":[185],"novel":[186],"UPLC-MS/MS":[187],"enables":[189],"rapid":[190],"accurate":[192],"determination":[193],"human":[198],"plasma,":[199],"which":[200],"suitable":[202],"therapeutic":[205],"drug":[206],"monitoring":[207],"(TDM)":[208],"baricitinib.":[210]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4411159595","counts_by_year":[{"year":2026,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2025-10-10T00:00:00"}
